Summary
5-Hydroxytryptamine (5-HT) contracts ring preparations of rabbit saphenous vein via direct and indirect components, the latter being- compatible with a “tyramine-like” action at sympathetic nerve terminals. Here an attempt was made to establish the identity of the receptor mediating contraction directly, in terms of the currently accepted proposals (Bradley et al. 1986).
Results with agonists suggested 5-HT1-like receptor activation: methysergide behaved as a partial agonist with microcolar affinity and 5-HT effects were mimicked by 5-carboxamidotryptamine (5-CT) and GR43175. The agonist potency order was 5-CT > 5-HT > methysergide ≥ GR43175, the same as that reported at the 5-HT1-like receptor in dog saphenous vein (Feniuk et al. 1985; Humphrey et al. 1988). Consistent with this, 5-HT effects were resistant to blockade by the selective 5-HT3 receptor antagonist MDL72222 (1.0 μmol/l). In contrast, methiothepin (0.01–0.3 μmol/l), ketanserin (0.3–30.0 μmol/l) and spiperone (0.3–30.0 μmol/l) each produced surmountable antagonism which, although competitivv in nature only for methiothepin (pKB = 9.45 ± 0.09, 17 d. f.), implied 5-HT2 receptor involvement. The possibility that these discrepancies resulted from mixed populations of 5-HT1-like and 5-HT2 receptors can be excluded because; 1). Ketanserin and spiperone blocked the actions of 5-HT and the selective 5-HT1-like receptor agonist GR43175 with equal facility and 2). Responses to all of the agonists studied were similarly antagonised by flesinoxan (pKB∼ 6.4), a simple competitive antagonist at the receptor in rabbit saphenous vein. This novel result with flesinoxan demonstrates that the ligand displays affinity at 5-HT receptors other than the 5-HT1A subtype.
These data show that the 5-HT receptor in rabbit saphenous vein shares features in common with, and may be identical to, the 5-HT1-like receptor in dog saphenous vein. However, unlike the latter it demonstrates qualities evident in both 5-HT1-like and 5-HT2 receptors and for this reason fails to meet the currently accepted criteria for admission into any of the recognised classes. It is suggested that this sort of problem reflects the generally unreliable behaviour of the available receptor antagonists and the emphasis which the Bradley et al. (1986) scheme places upon them for classification by exclusion. A complementary approach which provides a rigorous, quantitative basis for receptor differentiation uses “finger-prints” comprising affinity and relative efficacy estimates for a set of tryptamines. This study illustrates the power and economy of this approach by showing how affinity and relative efficacy “finger-prints” obtained using 5-HT, 5-CT, (±) α-methyl-5-HT, 5-methyltryptamine and N,N-dimethyltryptamine establish a positive identity for the 5-HT receptor in rabbit saphenous vein and at the same time enable it to be distinguished from other 5-HT receptor types presently allocated to the 5-HT1-like, 5-HT2 and so-called “orphan” receptor classes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Apperley E, Humphrey PPA (1986) The interaction of 5-hydroxytryptamine and methysergide with methiothepin at “5-HT1-like” receptors in dog saphenous vein. Br J Pharmacol 87:131P
Apperley E, Humphrey PPA, Levy GP (1976) Receptors for 5-HT and noradrenaline in rabbit isolated ear artery and aorta. Br. J Pharmacol 58:215–224
Apperley E, Feniuk W, Humphrey PPA, Levy GP (1980) Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vaculature. Br J Pharmacol 68:215–224
Barrett VJ, Leff P, Martin GR, Richardson PJ (1986) Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in the rabbit aorta. Br J Pharmacol 87:487–494
Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B 220:141–162
Black JW, Leff P, Shankley NP and Wood J (1985) An operational model of agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84:561–571
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Clarke DE, Craig DA, Fozard JR (1989) The 5-HT4 receptor: naughty, but nice. Trends Pharmacol Sci 10:385–386
Clineschmidt BV, Reiss DR, Pettibone DJ, Robinson JL (1985) Characterisation of 5-hydroxytryptamine receptors in rat stomach fundus. J Pharmacol Exp Ther 235:696–708
Cohen ML, Fludzinski LA (1987) Contractile sertonergic receptor in rat stomach fundus. J Pharmacol Exp Ther 243:264–269
Connell LA; Wallis DI (1988) Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat. Br J Pharmacol 94:1101–1114
Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887
Feniuk W, Humphrey PPA, Perren MJ, Watts AD (1985) A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697–704
Furchgott RF (1966). The use of \-haloalkylamines in the differentation of receptors and determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3:21–55
Gaddum JH, Picarelli ZP (1957) Two kind of tryptamine receptor. Br J Pharmacol 12:323–328
Hooker CW, Calkins PJ, Fleisch JH (1977) On the measurement of vascular and respiratory smooth muscle responses in vitro. Blood Vessels 14:1–11
Hoyer D (1989) 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Fozard JR (ed) The Peripheral Actions of 5-Hydroxytryptamine. Oxford University press, pp72–99
Humphrey PPA (1978) The effects of α-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol 63:671–675
Humphrey PPA, Richardson B (1989) Classification of 5-HT receptors and binding sites: An overview. In: Mylecharane EJ, Angus JA, de la Lande IS, Humphrey PPA (eds) Serotonin: Actions, Receptors, Pathophysiology. Proceedings of a Satellite Symposium of the IUPHAR 10th International Congress of Pharmacology, Macmillan, London, pp 204–221
Humphrey PPA, Feniuk W, Watts AD (1982) Ketanserin — a novel antihypertensive drug? J Pharm Pharmacol 34:541
Humphrey PPA; Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates IH, Butina D (1988) GR43175, a selective agonist for the 5-HT1-like receptor in dog saphenous vein. Br J Pharmacol 94:1123–1132
Iversen LL (1965) The inhibition of noradrenaline uptake by drugs. Adv Drug Res 2:5–23
Jaim-Etcheverry G, Zieher LM (1969) Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. I. Localization of exogenous 5-hydroxytryptamine in the autonomic nerves of the rat vas deferens. J Pharmacol Exp Ther 166:264–271
Leff P, Martin GR (1986) Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists? Br J Pharmacol 88:585–593
Leff P, Martin GR (1988) The classification of 5-hydroxytryptamine receptors. Med Res Rev 8:187–202
Leff P, Martin GR, Morse JM (1986) The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues. Br J Pharmacol 89:493–499
Leff P, Martin GR, Morse JM (1987) Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Br J Pharmacol 91:321–331
Maayani S, Wilkinson WC, Stollak J (1984) 5-HT receptor in the rabbit aorta: characterisation with some butyrophenone analogs. J Pharmacol Exp Ther 229:346–350
Martin GR, Sparrowhawk KT (1989) The putative 5-HT1A receptor in guinea-pig ileum: differential classification using tryptamines. Br J Pharmacol 98:757P
Martin GR, Leff P, Cambridge D, Barrett VJ (1987) Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn-Schmiedeberg's Arch Pharmacol 336: 365–373
Martin GR, Leff P, MacLennan SJ, Dougall I (1988) Three types of “5-HT1-like” receptor recognised by tryptamine affinity and efficacy “fingerprints”. Br J Pharmacol 95: 626P
Martin GR, Leff P, MacLennan SJ (1990) Tryptamine fingerprints in the classification of 5-HT receptors. In: Saxena PR, Bevan P (Eds) Cardiovascular Pharmacology of 5-hydroxytryptamine: Prospective Therapeutic Applications. Kluwer, Dordrecht, pp 157–162
Mylecharane EJ (1990) Agonists and antagonists of 5-HT2 receptors. In: Saxena PR, Bevan P (eds) Cardiovascular Pharmacology of 5-hydroxytryptamine: Prospective Therapeutic Applications. Kluwer, Dordrecht, pp 81–100
Pluchino S (1972) Direct and indirect effects of 5-HT and tyramine on cat smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 272:189–224
Schoeffter P, Hoyer D (1988) Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol 95:975–985
Thoa NB, Eccleston D, Axelrod J (1969) The accumulation of C14-serotonin in the guinea-pig vas deferens. J Pharmacol Exp Ther 169:68–73
Trendelenburg U (1960) The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J Physiol 130:450–460
Trist DG, Leff P (1985) Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assay. Agents Actions 16:222–226
Wouters W, Tulp M Th.M, Bevan P (1988) Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors. Eur J Pharmacol 149:213–223
Author information
Authors and Affiliations
Additional information
7Send offprint requests to G. R. Martin at the above address
Rights and permissions
About this article
Cite this article
Martin, G.R., MacLennan, S.J. Analysis of the 5-HT receptor in rabbit saphenous vein examplifies the problems of using exclusion criteria for receptor classification. Naunyn-Schmiedeberg's Arch Pharmacol 342, 111–119 (1990). https://doi.org/10.1007/BF00166952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00166952